The 15% increase in flow-mediated dilatation in this short-term trial of oral progesterone did not reach statistical significance, probably because of a lack of power.
← all excerpts
Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women.
1
—
—